179 related articles for article (PubMed ID: 32955679)
1. Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model.
Belgorosky D; Girouard J; Langle YV; Hamelin-Morrissete J; Marino L; Agüero EI; Malagrino H; Reyes-Moreno C; Eiján AM
J Mol Med (Berl); 2020 Nov; 98(11):1615-1627. PubMed ID: 32955679
[TBL] [Abstract][Full Text] [Related]
2. Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment.
Langle YV; Balarino NP; Belgorosky D; Cresta Morgado PD; Sandes EO; Marino L; Bilbao ER; Zambrano M; Lodillinsky C; Eiján AM
Nitric Oxide; 2020 May; 98():50-59. PubMed ID: 32147582
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nitric oxide is a good therapeutic target for bladder tumors that express iNOS.
Belgorosky D; Langle Y; Prack Mc Cormick B; Colombo L; Sandes E; Eiján AM
Nitric Oxide; 2014 Jan; 36():11-8. PubMed ID: 24211345
[TBL] [Abstract][Full Text] [Related]
4. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.
Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A
J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314
[TBL] [Abstract][Full Text] [Related]
5. SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
Zhu F; Qian W; Zhang H; Liang Y; Wu M; Zhang Y; Zhang X; Gao Q; Li Y
Stem Cell Reports; 2017 Aug; 9(2):429-437. PubMed ID: 28793245
[TBL] [Abstract][Full Text] [Related]
6. Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways.
Girouard J; Belgorosky D; Hamelin-Morrissette J; Boulanger V; D'Orio E; Ramla D; Perron R; Charpentier L; Van Themsche C; Eiján AM; Bérubé G; Reyes-Moreno C
Biochem Pharmacol; 2020 Jun; 176():113778. PubMed ID: 31877271
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase and PPARγ are involved in bladder cancer progression.
Sandes EO; Lodillinsky C; Langle Y; Belgorosky D; Marino L; Gimenez L; Casabé AR; Eiján AM
J Urol; 2012 Sep; 188(3):967-73. PubMed ID: 22819108
[TBL] [Abstract][Full Text] [Related]
8. A SNP of miR-146a is involved in bladder cancer relapse by affecting the function of bladder cancer stem cells via the miR-146a signallings.
Wang T; Yang Y; Wang Z; Zhang X; Li D; Wei J
J Cell Mol Med; 2020 Aug; 24(15):8545-8556. PubMed ID: 32596945
[TBL] [Abstract][Full Text] [Related]
9. iNOS expression and NO production contribute to the direct effects of BCG on urothelial carcinoma cell biology.
Shah G; Zhang G; Chen F; Cao Y; Kalyanaraman B; See WA
Urol Oncol; 2014 Jan; 32(1):45.e1-9. PubMed ID: 24054867
[TBL] [Abstract][Full Text] [Related]
10. Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors.
Ferreira-Teixeira M; Parada B; Rodrigues-Santos P; Alves V; Ramalho JS; Caramelo F; Sousa V; Reis F; Gomes CM
Oncotarget; 2015 Nov; 6(34):36185-201. PubMed ID: 26452033
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis.
Lin Z; Chen S; Ye C; Zhu S
Urol Res; 2003 Aug; 31(4):232-5. PubMed ID: 12937869
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
[TBL] [Abstract][Full Text] [Related]
13. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
14. Comparison of inducible nitric oxide synthase mRNA expression in different airway portions and association with nitric oxide parameters from patients with asthma.
Sato Y; Chibana K; Horigane Y; Uchida N; Masawa M; Koike R; Nakamura Y; Watanabe T; Shiobara T; Arai R; Shimizu Y; Takemasa A; Ishii Y
Clin Exp Allergy; 2019 May; 49(5):582-590. PubMed ID: 30667100
[TBL] [Abstract][Full Text] [Related]
15. Expression of inducible nitric oxide synthase in tumoral and non-tumoral epithelia from bladder cancer patients.
Sandes EO; Faletti AG; Riveros MD; Vidal Mdel C; Gimenez L; Casabé AR; Eiján AM
Nitric Oxide; 2005 Feb; 12(1):39-45. PubMed ID: 15631946
[TBL] [Abstract][Full Text] [Related]
16. Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer.
Lee SR; Roh YG; Kim SK; Lee JS; Seol SY; Lee HH; Kim WT; Kim WJ; Heo J; Cha HJ; Kang TH; Chung JW; Chu IS; Leem SH
Clin Cancer Res; 2015 Dec; 21(23):5391-403. PubMed ID: 26268246
[TBL] [Abstract][Full Text] [Related]
17. Localization and expression of inducible nitric oxide synthase in patients after BCG treatment for bladder cancer.
Koskela LR; Poljakovic M; Ehrén I; Wiklund NP; de Verdier PJ
Nitric Oxide; 2012 Oct; 27(3):185-91. PubMed ID: 22819699
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA AK023096 interacts with hnRNP-K and contributes to the maintenance of self-renewal in bladder cancer stem-like cells.
Zhao F; Qin S; Huang L; Ding L; Shi X; Zhong G
Exp Cell Res; 2021 Dec; 409(2):112909. PubMed ID: 34742742
[TBL] [Abstract][Full Text] [Related]
19. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
